General Biologicals Debuts Circulating Tumor Cell Cancer Detection Products
GBC’s two CTC detection systems are used for early detection, treatment validation, and therapy monitoring with rapid diagnostic solutions.
Read More
Search Results for: lung cancer
New Report Highlights Public Health Risks from Diagnostic Error
An estimated 795,000 Americans die or are permanently disabled by diagnostic error each year, according to a new analysis of national data.
Read More
AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage
CareDx, Inc. has announced that its AlloSure Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.
Read More
Lung Cancer Mortality Risk Predicted by Blood Test
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read More
PARIS Test Finds Unexpected Cancer Treatment Options
By testing a range of therapies in organoids grown from the patient’s own tumor sample, SEngine’s PARIS Test identified off-label therapy that proved highly successful for one ovarian cancer patient.
Read More